Search

247 results for “Reporting”

• Review ArticleOpen Access

  Therapeutics Effects of the Genus Citrus in Anxiety Disorder

  Hardeep Kaur, Ujjwal Kaushik, Neeraj Choudhary

  Vol. 15 · Issue 4 · pp. 373–388

  https://doi.org/10.1177/0976500X241278037
  Full text ↗PDF

• Case ReportOpen Access

  The Management of Shvitra (Leukoderma) with Rakta mokshna (Jalauka vidhi) and Vaman vidhi: A Case Study

  Kamal Vyas, Bhushan Mahiskar, Preeti Borkar, Pratyendra Pal Singh, Pooja Basnal, Khushali Balpande

  Vol. 14 · Issue 4 · pp. 296–301

  https://doi.org/10.1177/0976500X231225287
  Full text ↗PDF

• Case ReportOpen Access

  A case of figurate urticaria by etanercept

  Maurizio Sessa, Maria Giuseppa Sullo, Annamaria Mascolo, Daniela Cimmaruta, Francesca Romano, Rosa Valentina Puca, Annalisa Capuano, Francesco Rossi, Ada Lo Schiavo

  Vol. 7 · Issue 2 · pp. 106–108

  https://doi.org/10.4103/0976-500X.184777
  Full text ↗PDF

• Case ReportOpen Access

  Efficacy of Agnikarma (Cauterization) in the Management of Mashaka (Elevated Mole): A Case Study

  Jagrati Gautam, Bhushan Mhaiskar, Sonia Mandal, Pratyendra Pal, Priyal Bansal

  Vol. 16 · Issue 1 · pp. 119–123

  https://doi.org/10.1177/0976500X241294109
  Full text ↗PDF

• Research ArticleOpen Access

  Cost-effectiveness and Side Effects of Using Heparin and Enoxaparin as a Treatment for COVID-19-associated Coagulopathy

  Nurul Iska Ulmarika Idris, Abdul Khairul Rizki Purba, Arifa Mustika, Anna Surgean Veterini, Mochamad Yusuf Alsagaff, Mohammad Qorib

  Vol. 14 · Issue 3 · pp. 220–230

  https://doi.org/10.1177/0976500X231217140
  Full text ↗PDF

• Research LetterOpen Access

  Therapeutic drug monitoring of modified release once daily tacrolimus in de novo renal transplant with conversion to a twice daily generic in the stable period

  Bellusci CP, Rocco C, Aulicino P, Mecikovsky D, Curras V

  Vol. 6 · Issue 3 · pp. 154–156

  https://doi.org/10.4103/0976-500X.162021
  Full text ↗PDF

• Research ArticleOpen Access

  Review of the Long-Term Effect of the Atypical Antipsychotic Medication on the Bone Mineral Density of the Pediatric Patient with Consideration of Autism Spectrum Disorder

  Wisam Al Jumaili, Ashraf Muzwagi

  Vol. 13 · Issue 1 · pp. 24–30

  https://doi.org/10.1177/0976500X221080296
  Full text ↗PDF

• Mini ReviewOpen Access

  Iptakalim: A novel multi-utility potassium channel opener

  (Kir6.1s) (Kir6.1s), regulatory sulphonylurea subunits (SUR).[3] IPT shows high selectivity for cardiac KATP (SUR2A/Kir6.2), vascular KATP (SUR2B/Kir6.1 or SUR6B/Kir6.2). Because

  Vol. 3 · Issue 1 · pp. 12–14

  https://doi.org/10.4103/0976-500X.92495
  Full text ↗PDF

• Research ArticleOpen Access

  Application of the Statin-Associated Muscle Symptoms-Clinical Index to a Cohort of Patients with Type 2 Diabetes Mellitus Undergoing Phlebotomy at an Endocrinology Clinic

  Nor Humaira Mohd Tajudin, Mathumalar Loganathan Fahrni, Rohana Abdul Ghani, Mohd Hazriq Awang, Hitesh Chopra, Ali Saleh Alkhoshaiban

  Vol. 15 · Issue 4 · pp. 389–399

  https://doi.org/10.1177/0976500X241268964
  Full text ↗PDF

• Research LettersOpen Access

  A retrospective study of extrapyramidal syndromes with second generation antipsychotics in the psychiatric unit of a tertiary care teaching hospital

  Kingshuk Lahon, Harsha M Shetty, Amith Paramel, Gyaneshwar Sharma

  Vol. 3 · pp. 266–268

  https://doi.org/10.4103/0976-500X.99435
  Full text ↗PDF

• EditorialOpen Access

  Push, promote or educate…musings of a pharmacologist on drug promotion

  Chanolean Shashindran

  Vol. 5 · Issue 4 · pp. 225–226

  https://doi.org/10.4103/0976-500X.142427
  Full text ↗PDF

• EditorialOpen Access

  Essential medicines for children: Should we focus on a priority list of medicines for the present?

  Gitanjali B

  Vol. 2 · Issue 1 · pp. 1–2

  https://doi.org/10.4103/0976-500X.77073
  Full text ↗PDF

• News and ViewsOpen Access

  ‘Drug abuse’ of a different ‘wave’ length

  G. Sivagnanam

  Vol. 3 · pp. 85–6

  Full text ↗PDF

• News and ViewsOpen Access

  Antidepressants

  G. Sivagnanam

  Vol. 3 · pp. 287–288

  Full text ↗PDF

• WebwiseOpen Access

  The pharmacovigilance toolkit

  P. Ravi Shankar

  Vol. 4 · Issue 4 · pp. 307–308

  Full text ↗PDF

• Research LettersOpen Access

  Effect of Stereospermum tetragonum DC. in alloxan induced diabetic rats

  Isabella Topno, B. Chennama, B. Yugandhar

  Vol. 3 · Issue 2

  https://doi.org/10.4103/0976-500X.95527
  Full text ↗PDF

• EditorialOpen Access

  Eminence or Evidence? The Volatility, Uncertainty, Complexity, and Ambiguity in Healthcare

  M. K. Unnikrishnan

  Vol. 8 · Issue 1 · pp. 1–2

  https://doi.org/10.4103/jpp.JPP_12_17
  Full text ↗PDF

• CorrespondenceOpen Access

  L-Asparaginase induced thrombosis in acute lymphoblastic leukemia

  Ketan P. Kulkarni

  Vol. 3 · Issue 3 · pp. 285–286

  https://doi.org/10.4103/0976-500X.99449
  Full text ↗PDF

• MethodsOpen Access

  Starting a pharmacovigilance center: Actions for implementation

  Mrinmoy Chakrabarty, Vijay Thawani

  Vol. 2 · Issue 4 · pp. 295–299

  https://doi.org/10.4103/0976-500X.85945
  Full text ↗PDF

• EditorialOpen Access

  Clinical trial ethics in India: One step forward, two steps back

  Anant Bhan

  Vol. 3 · Issue 2 · pp. 95–97

  https://doi.org/10.4103/0976-500X.95501
  Full text ↗PDF